Scott Gottlieb, M.D. - 2020 Recipient
23rd Commissioner of the Food and Drug Administration (FDA); Resident Fellow at the American Enterprise Institute (AEI); Partner at New Enterprise Associates (NEA)
Scott Gottlieb, M.D., is a physician and was the 23rd Commissioner of the U.S. Food and Drug Administration. His work focuses on advancing public health through innovative approaches to improving medical outcomes, reshaping healthcare delivery, and expanding consumer choice and safety. He is a resident fellow at the American Enterprise
Institute and a partner at the venture firm New Enterprise Associates.
Dr. Gottlieb is an advocate for advancing the health of patients, promoting access, and driving innovation. Historic advances in new policy distinguished his tenure at the FDA, in addition to a record number of approvals of novel drugs, medical devices, and generic medicines. Under his leadership, the FDA advanced new frameworks for modern, safe and effective oversight of gene therapies, cell based regenerative medicines, targeted drugs, and digital health devices. The agency also implemented reforms to standardize drug reviews, improved use of real-world evidence, and promoted policies to reduce death and disease from tobacco.
Dr. Gottlieb is an advocate for advancing the health of patients, promoting healthcare access, and driving innovation.
Previously, Dr. Gottlieb served as the FDA’s Deputy Commissioner for Medical and Scientific Affairs and before that, as a Senior Adviser to the Administrator of the Centers for Medicare and Medicaid Services. He is widely published in medical journals and periodicals, including The Wall Street Journal, The New York Times, and The Washington Post, and held editorial positions on the British Medical Journal and the Journal of the American Medical Association. Fortune Magazine recognized him as one of the “World’s 50 Greatest Leaders” in 2018 and 2019, and Time Magazine named him one of its “50 People Transforming Healthcare in 2018.”
Dr. Gottlieb was a practicing hospitalist and is an elected member of the National Academy of Medicine.